Eli Lilly & Co
LLY· NYSE
Released Jul 28, 2016
10-Q filed Jul 28, 2016, 28 days after period end · 0000059478-16-000399
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $5.40B | $4.98B | $4.94B | $5.93B |
| Net Income | $747.70M | $600.80M | $733.50M | $1.21B |
| EPS Diluted | $0.71 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $0.56 |
| $0.68 |
| $1.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.